It usually begins with what’s called a deep vein thrombosis, or a clot deep in the body — usually in the legs — that ruptures and travels into the lungs, causing a blockage in the pulmonary artery. Called a pulmonary embolism, the blockage can be fatal.But where time is of the essence, RapidAI announced on monday It is FDA-approved and the system is designed to help quickly identify PE and support treatment.
in San Mateo, California fast artificial intelligence Providing clinical decision support, doctors also use its AI-enabled imaging software to treat stroke patients. Its newly FDA-approved Rapid PE Triage and Notification is designed to automatically identify suspected central pulmonary embolism – a clot that may be found in a major or central artery in the lungs. According to the company, it then provides real-time notifications to physicians for faster triage of patients and faster adjustments to care teams, reducing overall time to treatment.
RapidAI’s FDA-approved rapid PE triage and notification is being used with its pulmonary embolism patient workflow solution, PE Rapid Workflow, to enable care teams to more easily manage the entire patient care process,
Pulmonary embolism and deep vein thrombosis, usually leading to PE, Killed approximately 100,000 people In the U.S. annually, according to the Centers for Disease Control and Prevention; and Study shows death rates are on the rise Especially in patients over 65 years old. Sudden death is the first “symptom” in a quarter of patients, According to the CDCso rapid detection and treatment of PE is critical.
While the exact number of people who experience PE or DVT is not known, it can affect as many as 900,000 people each year; according to the CDC, one in three people experience a recurrence of PE within 10 years. Fast, accurate diagnosis and treatment — from medications like blood thinners to surgery to remove clots — also help reduce complications such as leg swelling and pain in survivors.
“Based on our expertise in stroke, we believe this technology will help modernize PE care and significantly improve patient outcomes,” RapidAI CEO Karim Karti said in a statement. It’s about building solutions that address specific challenges associated with treating a variety of diseases, as well as communication and workflow issues facing hospitals around the world.”
Other companies are also using AI to detect conditions like PE without symptoms to help speed treatment.
Israel Aidok Has an FDA-approved AI pulmonary embolism screening tool designed to flag potential cases of PE incidental to chest CT scans. The technology helps clinicians triage high-risk patients so they can access care faster.
Photo: Egor Kulinich, Getty Images
